Why the study?
Are higher plasma adiponectin levels associated with a lower risk of acute coronary syndrome in patients undergoing coronary angiography?
Are higher plasma adiponectin levels associated with a lower risk of acute coronary syndrome in patients undergoing coronary angiography?
Answers are grounded in this paper and cite their sources.
Higher plasma adiponectin levels are independently associated with a lower risk of acute coronary syndrome, suggesting a potential protective role of this adipokine.
AIMS: Obesity is a risk factor for an acute coronary syndrome (ACS). The association between elevated body mass index (BMI) and ACS is independent of most traditional risk factors, suggesting a possible contribution of other body fat-related mediators. This study evaluated the association between adiponectin and ACS. METHODS AND RESULTS: Four hundred and ninety-nine patients undergoing coronary angiography were divided into a subgroup without (n = 331) and with ACS (n = 168). In multiple regression analysis, higher adiponectin levels were independently associated with a lower risk of ACS [odds ratio (OR) = 0.61; 95% CIs: 0.46-0.81; P < 0.001]. In contrast, a higher BMI, a history of myocardial infarction, C-reactive protein, and angiographic coronary artery disease severity were all associated with a higher risk. The greatest increase in risk for ACS was seen at adiponectin levels < or = 5.5 microg/mL. CONCLUSION: Higher plasma adiponectin levels are independently associated with a lower risk of ACS.
No takes yet. Share an insight, caveat, or question.
Wołk et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: